Liver Disease Therapy

Lactoferrin Fights Off Cell-Associated Hepatitis

Published in Hepatitis Weekly, December 3rd, 2001

by Sonia Nichols, senior medical writer - A recombinant form of the human breast milk protein lactoferrin can combat phagocytic liver cells sensitized to produce hepatitis.

Thus far, lactoferrin inhibition of sensitized Kupffer cells has only been proven in murine models, but researchers believe the recombinant protein, which has antibacterial and antifungal properties, could also be used for treating human hepatic disease.

Makoto Yamaguchi and associates at the Nutrition Science Institute of Meiji Dairies Corporation in Japan performed the series of animal model experiments, in which they administered recombinant lactoferrin to mice a day before...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-12-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry